TWST
Twist Bioscience Corporation
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$124.72
−3.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.42x
- Price / sales
- 19.01x
- Price / cash flow
- -154.71x
Enterprise value
- Enterprise value
- $8.1B
- EV / sales
- 18.85x
- EV / EBITDA
- -75.49x
- EV / EBIT
- -59.06x
- Market cap
- $8.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026